Wojtkiewicz Marta, Stachura Albert, Roszkowski Bartłomiej, Winiarska Natalia, Kazimierska Karolina, Stachura Kamilla
Department of Methodology, Medical University of Warsaw, 1B Banacha Street, 02-091, Warsaw, Poland.
National Medical Institute of the Ministry of the Interior and Administration, 137 Wołoska Street, 02-507, Warsaw, Poland.
Aesthetic Plast Surg. 2024 Dec;48(23):5147-5154. doi: 10.1007/s00266-024-04262-0. Epub 2024 Aug 6.
1,4-Butanediol ether (BDDE) is widely used as a cross-linker for hyaluronic acid in dermal fillers. The purpose of this scoping review was to determine the state of knowledge about the behaviour of cross-linked substances and safety of BDDE application. The rationale behind the review came from the clinical experience of one of the authors (KS), who noticed adverse reactions after BDDE-linked hyaluronan application. The scoping review was conducted according to PRISMA-ScR guidelines. Out of 399 articles, 52 met the inclusion criteria. Data on study design, sample/population, aims, methodology, outcomes and funding were extracted. Results were charted according to 6 subtopics: rheological properties, hydrogel stability, BDDE toxicity, immunogenicity, tissue interactions and clinical studies. In vitro, cross-linked hydrogels were characterized as effective fillers in terms of viscosity and elasticity; however, previously uncharacterized by-products of the cross-linking reaction were found. Most in vivo studies reported increased dermis regeneration, vascularization and anti-inflammatory cytokine release after implantation of BDDE-cross-linked substances. In clinical studies, BDDE was shown to sensitize subjects to 1,6-hexanediol ether and other substances found in epoxy resin systems. Occupational dermatitis and hypersensitivity reactions were documented. Our review shows that BDDE may have long-term adverse effects, which are overlooked in the safety assessment of fillers. Reviews on BDDE conducted so far have mostly been sponsored by the industry, potentially leading to incomplete reporting of adverse effects. A review of the occurrence of allergic reactions after commercial dermal filler use and analysis of possibly harmful by-products of BDDE hyaluronan degradation are needed.Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
1,4 - 丁二醇醚(BDDE)被广泛用作真皮填充剂中透明质酸的交联剂。本范围综述的目的是确定关于交联物质行为及BDDE应用安全性的知识现状。该综述的依据来自一位作者(KS)的临床经验,其在应用BDDE交联的透明质酸后注意到了不良反应。本范围综述按照PRISMA - ScR指南进行。在399篇文章中,52篇符合纳入标准。提取了关于研究设计、样本/人群、目的、方法、结果和资金等方面的数据。结果根据6个子主题进行梳理:流变学性质、水凝胶稳定性、BDDE毒性、免疫原性、组织相互作用和临床研究。在体外,就粘度和弹性而言,交联水凝胶被表征为有效的填充剂;然而,发现了交联反应中以前未被表征的副产物。大多数体内研究报告称,植入BDDE交联物质后真皮再生、血管生成和抗炎细胞因子释放增加。在临床研究中,BDDE被证明会使受试者对1,6 - 己二醇醚及环氧树脂体系中的其他物质敏感。记录了职业性皮炎和过敏反应。我们的综述表明,BDDE可能有长期不良影响,而这在填充剂的安全性评估中被忽视了。迄今为止对BDDE进行的综述大多由行业赞助,这可能导致不良反应报告不完整。需要对商业真皮填充剂使用后过敏反应的发生情况进行综述,并分析BDDE透明质酸降解可能产生的有害副产物。证据水平III 本刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述,请参考目录或作者在线指南www.springer.com/00266 。
Aesthetic Plast Surg. 2024-12
J Cosmet Dermatol. 2025-1
Toxicol In Vitro. 2021-2
Aesthetic Plast Surg. 2018-4
J Funct Biomater. 2022-8-13
Clin Cosmet Investig Dermatol. 2021-12-22
Expert Rev Med Devices. 2021-12